Vascular Dynamics

Vascular Dynamics

Medical Devices, 30 Fairbanks Ste 100, Irvine, California, 92618, United States, 11-50 Employees

vasculardynamics.com

  • LinkedIn

phone no Phone Number: 19*********

Who is VASCULAR DYNAMICS

Vascular Dynamics, Inc (VDI), based in Irvine, California, is developing an innovative endovascular platform technology to provide compelling treatment options for patients suffering from...

Read More

map
  • 30 Fairbanks Ste 100, Irvine, California, 92618, United States Headquarters: 30 Fairbanks Ste 100, Irvine, California, 92618, United States
  • 2008 Date Founded: 2008
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 8011 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VASCULAR DYNAMICS

Vascular Dynamics Org Chart and Mapping

Employees

Abegail Enriquez

Clinical Trial Associate

Marisa Grant

Clinical Project Manager

John McIntyre

Chief Operating Officer

Vu Ho

Director of Operations & Quality

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vascular Dynamics

Answer: Vascular Dynamics's headquarters are located at 30 Fairbanks Ste 100, Irvine, California, 92618, United States

Answer: Vascular Dynamics's phone number is 19*********

Answer: Vascular Dynamics's official website is https://vasculardynamics.com

Answer: Vascular Dynamics's revenue is $1 Million to $5 Million

Answer: Vascular Dynamics's SIC: 8011

Answer: Vascular Dynamics's NAICS: 621111

Answer: Vascular Dynamics has 11-50 employees

Answer: Vascular Dynamics is in Medical Devices

Answer: Vascular Dynamics contact info: Phone number: 19********* Website: https://vasculardynamics.com

Answer: Vascular Dynamics, Inc (VDI), based in Irvine, California, is developing an innovative endovascular platform technology to provide compelling treatment options for patients suffering from life-threatening conditions underserved by conventional treatments. The companys MobiusHD technology features the first endovascular device to use the bodys natural baroreflex mechanism to modulate the autonomic nervous system. The endovascular baroreflex amplification (EVBA) approach targets both afferent and efferent neural pathways to realize a reduction in sympathetic tone and an increase in parasympathetic activity. Clinical evaluations of this unique baroreflex modulation therapy for heart failure and high-risk hypertensive patients are in progress.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access